Lineage Cell Therapeutics In shares owned by UBS Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $352k | 208k | 1.69 |
| 2025-06-30 | $206k | 228k | 0.91 |
| 2025-03-31 | $119k | 264k | 0.45 |
| 2024-12-31 | $111k | 221k | 0.50 |
| 2024-09-30 | $150k | 171k | 0.88 |
| 2024-06-30 | $77k | 77k | 1.00 |
| 2024-03-31 | $210k | 140k | 1.50 |
| 2023-12-31 | $163k | 145k | 1.13 |
| 2023-09-30 | $63k | 53k | 1.19 |
| 2023-06-30 | $87k | 61k | 1.42 |
| 2023-03-31 | $4.9k | 3.3k | 1.50 |
| 2022-12-31 | $12k | 11k | 1.15 |
| 2022-09-30 | $0 | 1.3k | 0.00 |
| 2022-06-30 | $13k | 11k | 1.12 |
| 2022-03-31 | $1.0k | 894 | 1.12 |
| 2021-12-31 | $89k | 40k | 2.24 |
| 2021-09-30 | $485k | 208k | 2.33 |
| 2021-06-30 | $15k | 4.5k | 3.36 |
| 2021-03-31 | $17k | 7.3k | 2.33 |
| 2020-12-31 | $55k | 25k | 2.24 |
| 2020-09-30 | $1.3k | 1.1k | 1.12 |
| 2020-06-30 | $1.5k | 1.4k | 1.12 |
| 2020-03-31 | $59k | 71k | 0.83 |
| 2019-12-31 | $173k | 156k | 1.11 |
| 2019-09-30 | $82k | 84k | 0.98 |